Delivery Order SPE2DB22D1106-SPE2DB25FEQS9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Januvia 100 mg tablets (90-count packages) with a ceiling value of $1,056.72. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order is set to be completed by November 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $1,056.72. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the competitive nature...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,091.46. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents pharmaceutical procurement to support federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Januvia 100 mg tablets (1,000 count) under a firm fixed-price contract valued at $22,743.64. The order is scheduled for completion by December 12, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Januvia 100 mg tablets in a 90-count quantity. This competitively awarded, non-set-aside contract has a ceiling value of $1,420.02 and is classified as a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Januvia 100 mg tablets (90-count packages) with a ceiling value of $8,167.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a small-value transaction within the broader...
- The Defense Logistics Agency awarded a competitively bid delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $16,310.52. This firm fixed-price delivery order, effective through November 5, 2025, represents a continuation of the prime contractor's role as a critical pharmaceutical supplier within the federal medical supply chain. The award was issued under a non-set-aside competitive procurement process...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $1,066.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQS9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, effective through May 30, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's pharmaceutical distribution capabilities to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains to fulfill the Department of Defense's healthcare supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/29/25 |